Knee osteoarthritis: key treatments and implications for physical therapy
LO Dantas, T de Fátima Salvini… - Brazilian journal of physical …, 2021 - Elsevier
Background Knee osteoarthritis (OA) is a chronic progressive disease that imparts a
substantial socioeconomic burden to society and healthcare systems. The prevalence of …
substantial socioeconomic burden to society and healthcare systems. The prevalence of …
Arthroscopic versus open treatment of femoroacetabular impingement: a systematic review of medium-to long-term outcomes
BU Nwachukwu, BJ Rebolledo… - … American journal of …, 2016 - journals.sagepub.com
Background: Surgical treatment of symptomatic femoroacetabular impingement (FAI) aims to
improve symptoms and potentially delay initiation of hip osteoarthritis and prevent …
improve symptoms and potentially delay initiation of hip osteoarthritis and prevent …
Phase 3 trial of RNAi therapeutic givosiran for acute intermittent porphyria
M Balwani, E Sardh, P Ventura, PA Peiró… - New England journal …, 2020 - Mass Medical Soc
Background Up-regulation of hepatic delta-aminolevulinic acid synthase 1 (ALAS1), with
resultant accumulation of delta-aminolevulinic acid (ALA) and porphobilinogen, is central to …
resultant accumulation of delta-aminolevulinic acid (ALA) and porphobilinogen, is central to …
Quantifying success after total shoulder arthroplasty: the minimal clinically important difference
R Simovitch, PH Flurin, T Wright, JD Zuckerman… - Journal of shoulder and …, 2018 - Elsevier
Background Knowledge of the minimal clinically important difference (MCID) for different
shoulder outcome metrics and range of motion after total shoulder arthroplasty (TSA) can be …
shoulder outcome metrics and range of motion after total shoulder arthroplasty (TSA) can be …
The minimal clinically important difference for Knee Society Clinical Rating System after total knee arthroplasty for primary osteoarthritis
Abstract Purpose The Knee Society Clinical Rating System (KS) is one of the most popular
tools used to assess patient outcome after total knee arthroplasty (TKA), but its minimal …
tools used to assess patient outcome after total knee arthroplasty (TKA), but its minimal …
Efficacy and safety of givosiran for acute hepatic porphyria: 24‐month interim analysis of the randomized phase 3 ENVISION study
P Ventura, HL Bonkovsky, L Gouya… - Liver …, 2022 - Wiley Online Library
Abstract Background & Aims Upregulation of hepatic delta‐aminolevulinic acid synthase 1
with accumulation of potentially toxic heme precursors delta‐aminolevulinic acid and …
with accumulation of potentially toxic heme precursors delta‐aminolevulinic acid and …
Reducing opioid use for chronic pain with a group-based intervention: a randomized clinical trial
Importance Opioid use for chronic nonmalignant pain can be harmful. Objective To test
whether a multicomponent, group-based, self-management intervention reduced opioid use …
whether a multicomponent, group-based, self-management intervention reduced opioid use …
Cemented versus cementless total knee arthroplasty of the same modern design: a prospective, randomized trial
D Nam, CM Lawrie, R Salih, CR Nahhas, RL Barrack… - JBJS, 2019 - journals.lww.com
Background: Highly porous surfaces promoting biologic fixation have renewed interest in
cementless total knee arthroplasty (TKA), but the potential for failed biologic fixation remains …
cementless total knee arthroplasty (TKA), but the potential for failed biologic fixation remains …
Minimum clinically important difference: current trends in the orthopaedic literature, part II: lower extremity: a systematic review
AG Copay, B Eyberg, AS Chung, KS Zurcher… - JBJS …, 2018 - journals.lww.com
Background: The minimum clinically important difference (MCID) attempts to define the
patient's experience of treatment outcomes. Efforts at calculating the MCID have yielded …
patient's experience of treatment outcomes. Efforts at calculating the MCID have yielded …
[HTML][HTML] Efficacy and safety of givosiran for acute hepatic porphyria: Final results of the randomized phase III ENVISION trial
DJ Kuter, HL Bonkovsky, S Monroy, G Ross… - Journal of …, 2023 - Elsevier
Background & Aims Acute hepatic porphyria (AHP) is caused by defects in hepatic heme
biosynthesis, leading to disabling acute neurovisceral attacks and chronic symptoms. In …
biosynthesis, leading to disabling acute neurovisceral attacks and chronic symptoms. In …